Abbott Laboratories is a defensive health care stock that offers a 2.1% yield. The dividend received a boost due to the firm's decision to raise the dividend for the 53rd consecutive year.

Total revenue was down 3% on a year-over-year basis. Revenue fell 4% year-over-year in the U.S., but International revenue grew 6% year-over-year. Here’s a breakdown of revenue by segment ...

SABRA HEALTH CARE Hedge Fund Activity We have seen 188 institutional investors add shares of SABRA HEALTH CARE stock to their portfolio, and 154 decrease their positions in their most recent quarter.

Simplify’s rules allow up to 20% of assets to fall outside health care, and, when shares were tra­ding below $4, off from a $32 high, the fund star­ted buying. PureCycle recently closed above $7.

The best-performing health care stocks in the last month returned at least 66.3%. An aging population and increasing medical needs are two factors contributing to massive growth in the health sector.

Abbott Laboratories is a defensive health care stock that offers a 2.1% yield. The dividend received a boost due to the firm’s decision to raise the dividend for the 53rd consecutive year.